The company said it does not source the active pharmaceutical
ingredients (API) of the drug from China, adding that supply of some
other APIs was impacted by the coronavirus.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/sun-pharma-flags-hypertension-drug-shortage-due-to-supply-constraint/articleshow/74439791.cms
No comments:
Post a Comment